Gelonghui, March 28 | Xinhua Pharmaceutical (000756.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 8.101 billion yuan, up 7.97% year on year; net profit attributable to shareholders of listed companies was 497 million yuan, up 20.79% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 462 million yuan, up 21.94% year on year; basic income per share was 0.74 yuan; it plans to distribute 2.5 yuan (tax included) to all shareholders for every 10 shares.
新华制药(000756.SZ)：2023年度净利润增20.79%至4.97亿元 拟10派2.5元
Xinhua Pharmaceutical (000756.SZ): Net profit increased by 20.79% to 497 million yuan in 2023, plans to distribute 10 to 2.5 yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.